Intervention
Hearing intervention (ACHIEVE protocol)
Research Observatory
Evidence Update
Current evidence
In ACHIEVE, a hearing intervention did not significantly improve three-year cognitive change overall compared with health education in adults aged 70–84 with untreated hearing loss and without substantial cognitive impairment. The result does not prove equivalence or negate other benefits of hearing treatment. Recruitment-subgroup findings remain a separate specialist-review question, not a demonstrated reduction in dementia diagnoses.
What changed
ACHIEVE did not improve three-year global cognitive change in its overall randomized population.
How to read these findings
The main randomized comparison did not show better cognitive change overall. This does not prove identical effects or rule out other benefits of hearing treatment.
ARIC names a recruitment cohort, not the whole trial. Recruitment-subgroup evidence remains on specialist hold. Any subgroup percentage mentioned in the exact technical boundary below is not an accepted benefit claim and is not a dementia-incidence result.
Accepted limitations and study details
Exact reviewed qualifications are retained below. These details do not add a new accepted claim.
Overall trial and held-subgroup boundary — no accepted subgroup benefit
- Hearing treatment can have noncognitive benefits; primary cognitive null is not equivalence or proof against those benefits.
- Design: Randomized active-control trial; prespecified recruitment-stratified sensitivity analysis
- Safety: No significant intervention-attributed adverse events in abstract; not a comprehensive device-safety conclusion.
- Interpretation: 48% is cognitive decline within ARIC, not dementia incidence or whole trial result.
Why it matters
These findings apply to the studied populations, regimens and outcomes; they do not establish generalized longevity benefit.
Next proof
Longer clinical cognitive outcomes and independent replication.